AVRAMEAS; Stratis

Patent Applications and Registrations

Patent applications and USPTO patent grants for AVRAMEAS; Stratis.The latest application filed is for "immunovectors which can be used for the intracellular and intranuclear transport".

Company Profile

0.15.4

AVRAMEAS; Stratis - Paris FR
Avrameas; Stratis - La Celle Saint Cloud FR
Avrameas; Stratis - La Celle St-Cloud FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Immunovectors Which Can Be Used For The Intracellular And Intranuclear Transport App 20110020928 - AVRAMEAS; Stratis ; et al.	2011-01-27
Vectors derived from antibodies for transferring substances into cells Grant 7,628,987 - Ternynck , et al. December 8, 2	2009-12-08
Vectors derived from antibodies for transferring substances into cells App 20070098741 - Ternynck; Therese ; et al.	2007-05-03
Immunovectors which can be used for the intracellular and intranuclear transport App 20040259822 - Avrameas, Stratis ; et al.	2004-12-23
Vectors derived from antibodies for transferring substances into cells App 20030206900 - Ternynck, Therese ; et al.	2003-11-06
Single-chain antibody fragments for transferring substances into cells Grant 6,635,248 - Ternynck , et al. October 21, 2	2003-10-21
Immunovectors for the intracellular and intranuclear transport Grant 6,608,034 - Avrameas , et al. August 19, 2	2003-08-19
Method of detecting and characterizing a nucleic acid or reactant for the application of this method Grant 5,955,262 - Kourilsky , et al. September 21, 1	1999-09-21
Method of detecting and characterizing a nucleic acid or a sequence of the latter, and enzymatic reactant for the application of this method Grant 5,876,928 - Kourilsky , et al. March 2, 1	1999-03-02
Method of detecting and characterizing a nucleic acid or a sequence of the latter, and enzymatic reactant for the application of this method Grant 5,605,800 - Kourilsky , et al. February 25, 1	1997-02-25
Process for the detection and assay by erythroadsorption Grant 4,729,961 - Avrameas , et al. * March 8, 1	1988-03-08
Method for detecting and dosing by erythroadsorption a biological substance Grant 4,668,637 - Guesdon , et al. May 26, 1	1987-05-26
Process for coupling biological substances by covalent bonds Grant 4,592,998 - Avrameas , et al. * June 3, 1	1986-06-03
Method of detecting and characterizing a nucleic acid or reactant for the application of this method Grant 4,581,333 - Kourilsky , et al. April 8, 1	1986-04-08
Conjugate obtained by coupling a lectin and a specific ligand, containing such a conjugate and its applications in biology Grant 4,526,871 - Avrameas , et al. July 2, 1	1985-07-02
Immobilization of active protein by cross-linking to inactive protein Grant 4,464,468 - Avrameas , et al. August 7, 1	1984-08-07
Magnetic gel suitable to immunoenzymatic determinations Grant 4,241,176 - Avrameas , et al. December 23, 1	1980-12-23
Process for coupling biological substances by covalent bonds Grant 4,193,982 - Avrameas , et al. March 18, 1	1980-03-18
Preparation of active proteins cross-linked to inactive proteins Grant 4,004,979 - Avrameas , et al. January 25, 1	1977-01-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.